The Biotech That Has Almost Doubled in 2017 With the Potential to Boom Even More Post author:Sam Post published:November 21, 2017 Post category:BioPharma Keith Speights, writing for The Motley Fool, notes one biotech that’s booming. Source: BioSpace You Might Also Like Novartis Oncology Head to Retire for Personal Reasons December 14, 2017 Bioverativ To Report Second Quarter 2017 Financial Results On August 2, 2017 July 6, 2017 PAREXEL to Slash Up to 1,200 Jobs Worldwide May 9, 2017
